- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive: May 2023
From Science to Strategy | 2023 Emerging Pharma Leader
May 11, 2023
Executive Profile
43
5
How the pivot to corporate development became a natural fit for the once-destined scientist. (The story of Natasha A. Hernday, chief business officer of Seagen and a 2023 Emerging Pharma Leader.)
Committed to the Cause | 2023 Emerging Pharma Leader
May 11, 2023
Executive Profile
43
5
Driving commercial growth and patient access and empowerment in women’s health. (The story of Simon Holland, vice president, women's health commercial lead, for Organon and a 2023 Emerging Pharma Leader.)
A Knack for Problem-Solving | 2023 Emerging Pharma Leader
May 11, 2023
Executive Profile
43
5
The recipe for cross-functional collaboration in drug development. (The story of Justin To, chief operating officer, skeletal dysplasias and gene therapy, for Bridge Bio and a 2023 Emerging Pharma Leader.)
Mission-Fueled Mindset | 2023 Emerging Pharma Leader
May 11, 2023
Executive Profile
43
5
Chronicling one leader’s call to duty in dermatology. (The story of Frank Watanabe, president and CEO of Arcutis Biotherapeutics and a 2023 Emerging Pharma Leader.)
Rejuvenating Lives | 2023 Emerging Pharma Leader
May 11, 2023
Executive Profile
43
5
Scientist-turned-entrepreneur steers efforts to transform approaches in tissue regeneration. (The story of Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics and a 2023 Emerging Pharma Leader.)
Optimized for Growth? Revenue Management in Pharma
May 10, 2023
Feature
43
5
According to the latest State of Revenue survey of c-suite executives, pharma manufacturers are prioritizing digital transformation while struggling with inflation and supply chain disruptions.
A New Era for Market Access: Organizing the Function’s Broader Strategic Role
May 10, 2023
Feature
43
5
BCG’s 2022 benchmark study uncovers new competencies needed for pharma access leaders in enterprise-wide business strategy, where thoughtfully designed approaches and goals focused on shared priority and responsibility are increasingly important.
Preparing for the End of the COVID Health Emergency
May 09, 2023
Column
43
5
Areas of focus during phase-out include telehealth and patient access.
AI is a Tool, Not a Replacement for Employees
May 09, 2023
Column
43
5
The pluses for pharma are many—alongside experienced workers.
Ratings and Rankings: ESG Fundamentals for Pharma Leaders
May 09, 2023
Column
43
5
There is room to improve what good looks like across the industry.
Will Recent Surge in M&A Dealmaking Save Biotech Sector?
May 08, 2023
Column
43
5
The ‘blistering’ pace may further divide the haves from the have-nots.
Europe’s Drug Pricing Conundrums Coming to a Head
May 08, 2023
Column
43
5
More opinions enter the mix as EU launches legislation review.
Rise and Recognition
May 07, 2023
From the Editor
43
5
This year marks my first involvement in Pharmaceutical Executive’s Emerging Pharma Leaders (EPL) Awards, and what a ride it has been. We received so many wonderful nominations, and it’s always humbling to learn about some of the intricacies of the research that’s being done as well as the accomplishments of both current leaders and up-and-coming leaders.
Pharmaceutical Executive, May 2023 Issue (PDF)
May 07, 2023
Issue PDF
43
5
Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.